Novo Nordisk’s stock tumbled as drugmaker lays out case for declining sales in 2026
Up next
Author


The maker of Ozempic and Wegovy blamed pricing pressures and competition for its downbeat outlook.

You May Also Like
I was laid off. I’m 43 and my husband is 35. I have $8,000 in credit-card debt and our mortgage is $1,600 a month. What do we do?

I was laid off. I’m 43 and my husband is 35. I have $8,000 in credit-card debt and our mortgage is $1,600 a month. What do we do?

“We have been bringing in $60,000 a year for the last couple…
Qantas’s management exodus continues as loyalty chief quits

Qantas’s management exodus continues as loyalty chief quits

SYDNEY — The head of Qantas Airways’s loyalty division has quit the…
Fog of trade war hangs over economy, but the Fed still has to make a forecast. Here’s what it’s faces.

Fog of trade war hangs over economy, but the Fed still has to make a forecast. Here’s what it’s faces.

Is inflation going to speed up again? Are businesses going to stop…
Here’s who is behind the Reagan anti-tariff ads that got Trump to ditch trade talks with Canada

Here’s who is behind the Reagan anti-tariff ads that got Trump to ditch trade talks with Canada

Ontario’s center-right leader, Doug Ford, says he launched the $75 million U.S.…